CN103630684A - Test strip card - Google Patents
Test strip card Download PDFInfo
- Publication number
- CN103630684A CN103630684A CN201310565236.5A CN201310565236A CN103630684A CN 103630684 A CN103630684 A CN 103630684A CN 201310565236 A CN201310565236 A CN 201310565236A CN 103630684 A CN103630684 A CN 103630684A
- Authority
- CN
- China
- Prior art keywords
- test strip
- detection
- sample
- quality control
- card
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 241
- 238000001514 detection method Methods 0.000 claims abstract description 142
- 238000003908 quality control method Methods 0.000 claims abstract description 53
- 239000012528 membrane Substances 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 238000004458 analytical method Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002096 quantum dot Substances 0.000 claims description 12
- 239000000020 Nitrocellulose Substances 0.000 claims description 10
- 229920001220 nitrocellulos Polymers 0.000 claims description 10
- 239000004033 plastic Substances 0.000 claims description 10
- 229920000728 polyester Polymers 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 101100379079 Emericella variicolor andA gene Proteins 0.000 claims description 5
- 239000004677 Nylon Substances 0.000 claims description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 229920002301 cellulose acetate Polymers 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 239000003365 glass fiber Substances 0.000 claims description 5
- 239000006249 magnetic particle Substances 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 5
- 229920001778 nylon Polymers 0.000 claims description 5
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 5
- 150000002910 rare earth metals Chemical class 0.000 claims description 5
- 208000023275 Autoimmune disease Diseases 0.000 claims description 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 4
- 208000035473 Communicable disease Diseases 0.000 claims description 4
- 239000003124 biologic agent Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 238000011109 contamination Methods 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 238000003912 environmental pollution Methods 0.000 claims description 4
- 210000004392 genitalia Anatomy 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 239000000447 pesticide residue Substances 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 abstract description 2
- 238000002372 labelling Methods 0.000 description 18
- 238000010586 diagram Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 4
- 239000012491 analyte Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000004054 semiconductor nanocrystal Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/4875—Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention belongs to the field of in-vitro diagnosis, and particularly relates to a test strip card which is provided with a storage medium (12) for storing a tested object standard curve, coefficient parameters or other detection information. The test strip card comprises a card box (3) and a test strip (2) in the card box (3), wherein a storage medium (12) is installed on the card box (3). When detecting a sample, an instrument with signal detection function acquires characteristic signals of a test strip (2) detection belt (6) and a quality control belt (7) and calculates the sample single component or multicomponent concentration in combination with the tested object standard curve or coefficient parameters simultaneously red from the storage medium (12) by the instrument. The test strip card for detecting samples has is simple and quick, and has the characteristics of high sensitivity, objective result, high use flexibility and the like.
Description
Technical Field
The invention belongs to the field of in-vitro diagnosis, and particularly relates to a test strip card which is provided with a storage medium 12 for storing information for detection such as standard curves or coefficient parameters of a detected object and can be used for rapidly detecting single components or multiple components of a sample by combining with an instrument with a signal detection function.
Background
Immunochromatographic strip technology, which is mainly represented by a colloidal gold strip, is now widely used in various aspects of immunoassays. The technique is simple and rapid, and the result can be obtained within minutes. The disadvantages are as follows: (1) only can qualitatively detect the sample, is difficult to realize the quantitative detection of the sample, and is more difficult to realize the rapid quantitative detection of the multi-component of the sample. (2) For some samples with extremely low antigen or antibody content, the result is difficult to judge by naked eyes, and the detection sensitivity is low.
The method for quantifying the concentration of a detected object by using a standard curve of a detected object standard is a main method for quantifying the concentration of a sample in the field of detection at present. The standard curve making technology is strong, the process is complicated, and professional technicians cannot be left. Storage media developed recently in the information field, such as RFID tags (also called radio frequency identification tags), IC chips, magnetic codes, bar codes, etc., are now widely used in the fields of computers, communications, electronics, commerce, transportation control management, etc., for information access identification. The RFID label has small volume and large capacity of stored information, does not need manual intervention for identification, is an ideal means for information access identification, but rarely is used in the field of biomedical detection.
In order to overcome the defects of the prior art, the invention provides a test strip card which is provided with a storage medium 12 for storing information for detection such as a standard curve or coefficient parameters of a detected object (an operator does not need to make the standard curve of the detected object when detecting a sample) and can be combined with an instrument with a signal detection function to quickly realize single-component or multi-component quantitative (qualitative/semi-quantitative) detection of the sample. The invention is used for sample detection, and has the characteristics of simplicity, convenience, rapidness, high sensitivity, objective result and the like.
Disclosure of Invention
The technical scheme of the invention is as follows:
the test strip card of the present invention comprises a cartridge 3 and a test strip 2 therein. The test strip 2 comprises a sample pad 4, a marking pad 5, an analysis film 8 and a water absorption pad 9 which are sequentially overlapped and fixed on the bottom liner 1. The analytical membrane 8 has a detection zone 6 and a quality control zone 7. The upper case surface of the cartridge 3 is provided with a loading hole 10 at a position corresponding to the test strip sample pad 4. The upper case surface of the cartridge 3 is opened with a detection window 11 at a position corresponding to the test strip analysis film 8. The cartridge 3 is provided with a storage medium 12.
The label pad 5 of the test strip 2 is coated with a single specific molecule related to detection of a target analyte labeled with a single label, or: and detecting a mixture of related specific molecules by using each target object correspondingly marked by different markers.
The test strip 2 may have one or more test strips 6. The detection zone 6 is coated with another specific molecule related to the detection of a target object, or: coated with a mixture of other specific molecules relevant for the detection of each target test substance.
The quality control strip 7 of the test strip 2 is coated with a quality control substance. The quality control substance comprises a secondary antibody.
The storage medium 12 on the cartridge 3 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, a bar code, or the like. The storage medium 12 stores a standard curve or coefficient parameter of the detected object for quantifying the sample concentration of the same batch of test strips 2, a reference monitoring value of the signal intensity of the control band of the quality of the test strips, a batch number of the test strips, an expiration date of the test strips, a password of the storage medium, a reference value of clinical indexes, information of manufacturers of the test strips and the like, and can read the identity information, the information of testees, the name of the sample, the number of the sample, the detection date, the detection result and the like.
The standard curve of the object stored in the storage medium 12 can be selected in various forms, including but not limited to the following curves: concentration of standard substance series to be detectedA Detection belt/A Quality control bandThe corresponding relation curve between the two curves; or, the concentration of the standard substance series of the object to be tested andA detection belt/（A Detection belt+A Quality control band) The corresponding relation curve between the two. Wherein,A detection beltThe signal intensity of the detection zone measured for the series concentration of the object standard,A quality control bandAnd the signal intensity of the quality control band measured for the series concentration of the detected object standard.
The absorbent pad 9 of strip 2 of the present invention may be followed by a strip reaction endpoint indicator 13. Accordingly, the cartridge 3 has a viewing window 14 corresponding to the test strip reaction endpoint indicator 13. The test strip reaction endpoint indicator 13 includes, but is not limited to, a pH indicator strip with a color change in the range of 5-9.
The marking pad 5 of the test strip 2 is a glass fiber film; the analysis membrane 8 of the test strip 2 is a nitrocellulose membrane, a nylon membrane or a mixed membrane of nitrocellulose and cellulose acetate; the bottom liner 1 of the test strip 2 is made of polyester or a plastic plate; the cartridge 3 is made of polyester, plastic, rigid paper material, or other material.
The test strip 2 of the present invention is any test strip, including but not limited to quantum dot labeling test strip, colloidal gold labeling test strip, colloidal selenium labeling test strip, upconversion phosphor labeling test strip, nano rare earth fluorescent complex labeling test strip, nano magnetic particle labeling test strip, time resolution chromatography test strip, and chemiluminescence test strip.
After the test strip card finishes the test strip reaction of a tested object of the test strip, an instrument with a signal detection function (such as a strip reader, a fluorescence detector, a magnetic signal detector and the like) collects characteristic signals of a detection band 6 and a quality control band 7 of the test strip 2 and quantitatively obtains the single-component or multi-component concentration of a sample by combining with a standard curve or coefficient parameter of the tested object simultaneously read from a storage medium 12 by the instrument; or, the components of the sample are qualitatively or semi-quantitatively detected according to the display conditions of the test strip detection zone 6 and the quality control zone 7 of the test strip card.
The sample to be detected of the test strip card can be clinical or non-clinical blood, body fluid, urine, saliva, genital secretion or other liquid samples or viscous samples, wherein the clinical samples comprise samples of infectious diseases, hormones, cardiovascular diseases, tumors, cancers, diabetes, autoimmune diseases and the like, and the non-clinical samples comprise samples of food detection, environmental pollution detection, pesticide residue detection, biological contamination detection, biological agent detection, veterinary medicine detection, drug detection and the like.
The invention has the following beneficial effects:
(1) the sample components can be detected rapidly and quantitatively (including qualitative or semi-quantitative detection of the sample components). The test strip card of the present invention is provided with a storage medium 12, and the storage medium 12 stores information for detection such as a standard curve or a coefficient parameter of an object to be detected. After the chromatographic reaction of the sample to be detected on the test strip is completed, the instrument with the signal detection function collects the characteristic signals of the detection belt 6 and the quality control belt 7 of the test strip 2 in the test strip card and combines the standard curve or coefficient parameter of the detected object which is simultaneously read from the storage medium 12 by the instrument, so that the component concentration of the sample can be rapidly and quantitatively obtained within minutes.
(2) When the test strip 2 in the test strip card is marked by the quantum dots, the quick and accurate quantitative detection of multiple components of a sample can be realized simultaneously. Quantum Dots (QDs) are semiconductor nanocrystals which have excellent spectral characteristics and photochemical stability and are developed in the 90 s of the 20 th century, and have the characteristics of high fluorescence luminous efficiency, wide excitation spectral line range, narrow emission spectral line range, long fluorescence service life, large Stokes shift, similar particle size to biomolecules, multifunction after surface modification and the like. The quantum dots with different particle sizes, types and structures can generate continuous fluorescence peak spectrums with different characteristic wavelengths, and the fluorescence peak spectrums with the characteristic wavelengths generated by the quantum dot mixture are not overlapped. Different quantum dots are adopted to mark corresponding reaction molecules of a detected object respectively, a mixture of the different quantum dots is coated on a test strip of the test strip card to react with a sample to be detected, and the multi-component concentration of the sample can be rapidly and accurately quantified within a few minutes by measuring a specific fluorescence signal of the test strip. The existing test strip technology can only detect a sample qualitatively, cannot realize quantitative detection of the sample and cannot realize multi-component quantitative detection of the sample.
(3) The reagents and materials in the strip card are not subject to activity inactivation and can be stored at room temperature for a long period of time.
Drawings
FIG. l: the plan structure diagram of the first preferred scheme of the test strip card (the test strip in the test strip card adopts a detection line)
FIG. 2: side view structure diagram of test strip in card box (the test strip adopts a detection line)
FIG. 3: the plan structure diagram of the first preferred scheme of the test strip card (the test strip in the test strip card adopts a plurality of detection lines)
FIG. 4: side view structure diagram of test strip in card box (the test strip adopts a plurality of detection lines)
FIG. 5: another preferred embodiment of the test strip card of the present invention is a structure diagram of a top view (showing the test strip therein using one test line)
FIG. 6: side view structure diagram of test strip in card box of another preferred scheme of the test strip card of the invention (the test strip adopts a detection line)
FIG. 7: another preferred embodiment of the test strip card of the present invention is a structure diagram of a top view (showing the test strip therein using a plurality of test lines)
FIG. 8: side view structure diagram of test strip in card box of another preferred scheme of the test strip card of the invention (the test strip adopts a plurality of detection lines)
The sequence numbers are as follows:
1. the kit comprises a bottom lining, 2, a test strip, 3, a card box, 4, a sample pad, 5, a marking pad, 6, a detection strip, 7, a quality control strip, 8, an analysis film, 9, a water absorption pad, 10, a sample adding hole, 11, a detection window, 12, a storage medium, 13, a test strip reaction end point indication label, 14 and an observation window.
Detailed Description
The following examples and figures are only intended to illustrate the invention further and the person skilled in the art should not be construed as limiting the scope of the invention.
Example one
Fig. 1-4 illustrate a first embodiment. The first embodiment is one of the preferred solutions of the test strip card of the present invention.
In fig. 1-4, the test strip card of the preferred embodiment includes a cartridge 3 and a test strip 2 therein. The test strip 2 comprises a sample pad 4, a marking pad 5, an analysis film 8 and a water absorption pad 9 which are sequentially overlapped and fixed on the bottom lining 1. The analytical membrane 8 has a detection zone 6 and a quality control zone 7. The upper case surface of the cartridge 3 is provided with a loading hole 10 at a position corresponding to the test strip sample pad 4. The upper case surface of the cartridge 3 is opened with a detection window 11 at a position corresponding to the test strip analysis film 8. The cartridge 3 is provided with a storage medium 12.
The label pad 5 of the test strip 2 is coated with a single specific molecule related to detection of a target analyte labeled with a single label, or: and detecting a mixture of related specific molecules by using each target object correspondingly marked by different markers.
The test strip 2 may have one or more test strips 6 (shown in fig. 1 and 2) or a plurality of test strips 6 (shown in fig. 3 and 4). The detection zone 6 is coated with another specific molecule related to the detection of a target object, or: coated with a mixture of other specific molecules relevant for the detection of each target test substance.
The quality control strip 7 of the test strip 2 is coated with a quality control substance. The quality control substance comprises a secondary antibody.
The storage medium 12 on the cartridge 3 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, a bar code, or the like. The storage medium 12 stores a standard curve or coefficient parameter of the detected object for quantifying the sample concentration of the same batch of test strips 2, a reference monitoring value of the signal intensity of the control band of the quality of the test strips, a batch number of the test strips, an expiration date of the test strips, a password of the storage medium, a reference value of clinical indexes, information of manufacturers of the test strips and the like, and can read the identity information, the information of testees, the name of the sample, the number of the sample, the detection date, the detection result and the like.
The standard curve of the object stored in the storage medium 12 can be selected in various forms, including but not limited to the following curves: concentration of standard substance series to be detectedA Detection belt/A Quality control bandThe corresponding relation curve between the two curves; or, the concentration of the standard substance series of the object to be tested andA detection belt/（A Detection belt+A Quality control band) The corresponding relation curve between the two. Wherein,A detection beltThe signal intensity of the detection zone measured for the series concentration of the object standard,A quality control bandAnd the signal intensity of the quality control band measured for the series concentration of the detected object standard.
The marking pad 5 of the test strip 2 is a glass fiber film; the analysis membrane 8 of the test strip 2 is a nitrocellulose membrane, a nylon membrane or a mixed membrane of nitrocellulose and cellulose acetate; the bottom liner 1 of the test strip 2 is made of polyester or a plastic plate; the cartridge 3 is made of polyester, plastic, rigid paper material, or other material.
The test strip 2 is any test strip including, but not limited to, quantum dot labeling test strips, colloidal gold labeling test strips, colloidal selenium labeling test strips, upconversion phosphor labeling test strips, nano rare earth fluorescent complex labeling test strips, nano magnetic particle labeling test strips, time-resolved chromatography test strips, and chemiluminescence test strips.
When the test strip card is used for detecting a sample, a liquid sample is applied to a sample adding hole 10 of the test strip card, after the test strip 2 in the test strip card finishes reaction, characteristic signals of a detection band 6 and a quality control band 7 of the test strip 2 are collected by an instrument with a signal detection function (such as a strip reading instrument, a fluorescence detector, a magnetic signal detector and the like), and the single-component or multi-component concentration of the sample is quantitatively obtained by combining a standard curve or coefficient parameter of a detected object which is simultaneously read from a storage medium 12 of the test strip card by the instrument; or, the components of the sample are qualitatively or semi-quantitatively detected according to the display conditions of the test strip detection zone 6 and the quality control zone 7 of the test strip card.
The sample to be detected of the test strip card can be clinical or non-clinical blood, body fluid, urine, saliva, genital secretion or other liquid samples or viscous samples, wherein the clinical samples comprise samples of infectious diseases, hormones, cardiovascular diseases, tumors, cancers, diabetes, autoimmune diseases and the like, and the non-clinical samples comprise samples of food detection, environmental pollution detection, pesticide residue detection, biological contamination detection, biological agent detection, veterinary medicine detection, drug detection and the like.
Example two
Fig. 5-8 illustrate the second embodiment. The second embodiment is another preferred scheme of the test strip card of the invention.
In fig. 5-8, the test strip card of the preferred embodiment includes a cartridge 3 and a test strip 2 therein. The test strip 2 comprises a sample pad 4, a marking pad 5, an analysis film 8, a water absorption pad 9 and a test strip reaction endpoint indicator label 13 which are sequentially overlapped and fixed on the bottom lining 1. The analytical membrane 8 has a detection zone 6 and a quality control zone 7. The upper case surface of the cartridge 3 is provided with a loading hole 10 at a position corresponding to the test strip sample pad 4. The upper case surface of the cartridge 3 is opened with a detection window 11 at a position corresponding to the test strip analysis film 8. The upper case surface of the cartridge 3 is provided with a viewing window 14 at a position corresponding to the end point indicator label 13 of the test strip reaction. The cartridge 3 is provided with a storage medium 12.
The label pad 5 of the test strip 2 is coated with a single specific molecule related to detection of a target analyte labeled with a single label, or: and detecting a mixture of related specific molecules by using each target object correspondingly marked by different markers.
The test strip 2 may have one or more test strips 6 (shown in fig. 5 and 6) or strips 7 and 8. The detection zone 6 is coated with another specific molecule related to the detection of a target object, or: coated with a mixture of other specific molecules relevant for the detection of each target test substance.
The quality control strip 7 of the test strip 2 is coated with a quality control substance. The quality control substance comprises a secondary antibody.
The test strip reaction endpoint indicator 13 includes, but is not limited to, a pH indicator strip with a color change in the range of 5-9. During sample detection, the test strip reaction end point indicating label 13 on the test strip can be developed according to the pH condition of the test strip reaction to prompt whether the test strip reactant has sufficiently permeated through the detection zone 6 and the quality control zone 7 or not, so as to prompt whether the test strip reaction is sufficient or not and whether the detection result is effective or not.
The storage medium 12 on the cartridge 3 includes, but is not limited to, an RFID tag, an IC chip, a magnetic code, a bar code, or the like. The storage medium 12 stores a standard curve or coefficient parameter of the detected object for quantifying the sample concentration of the same batch of test strips 2, a reference monitoring value of the signal intensity of the control band of the quality of the test strips, a batch number of the test strips, an expiration date of the test strips, a password of the storage medium, a reference value of clinical indexes, information of manufacturers of the test strips and the like, and can read the identity information, the information of testees, the name of the sample, the number of the sample, the detection date, the detection result and the like.
The standard curve of the object stored in the storage medium 12 can be selected in various forms, including but not limited to the following curves: concentration of standard substance series to be detectedA Detection belt/A Quality control bandThe corresponding relation curve between the two curves; or, the concentration of the standard substance series of the object to be tested andA detection belt/（A Detection belt+A Quality control band) The corresponding relation curve between the two. Wherein,A detection beltThe signal intensity of the detection zone measured for the series concentration of the object standard,A quality control bandAnd the signal intensity of the quality control band measured for the series concentration of the detected object standard.
The marking pad 5 of the test strip 2 is a glass fiber film; the analysis membrane 8 of the test strip 2 is a nitrocellulose membrane, a nylon membrane or a mixed membrane of nitrocellulose and cellulose acetate; the bottom liner 1 of the test strip 2 is made of polyester or a plastic plate; the cartridge 3 is made of polyester, plastic, rigid paper material, or other material.
The test strip 2 is any test strip including, but not limited to, quantum dot labeling test strips, colloidal gold labeling test strips, colloidal selenium labeling test strips, upconversion phosphor labeling test strips, nano rare earth fluorescent complex labeling test strips, nano magnetic particle labeling test strips, time-resolved chromatography test strips, and chemiluminescence test strips.
When the test strip card is used for detecting a sample, a liquid sample is applied to a sample adding hole 10 of the test strip card, after a test strip reaction end point indicating label 13 of a test strip 2 in the test strip card indicates that the sample finishes reaction on the test strip 2, characteristic signals of a detection band 6 and a quality control band 7 of the test strip 2 are collected by an instrument with a signal detection function (such as a strip reader, a fluorescence detector, a magnetic signal detector and the like), and a detected object standard curve or coefficient parameter which is simultaneously read from a test strip card storage medium 12 by the instrument is combined to quantitatively obtain the single-component or multi-component concentration of the sample; or, the components of the sample are qualitatively or semi-quantitatively detected according to the display conditions of the test strip detection zone 6 and the quality control zone 7 of the test strip card.
The sample to be detected of the test strip card can be clinical or non-clinical blood, body fluid, urine, saliva, genital secretion or other liquid samples or viscous samples, wherein the clinical samples comprise samples of infectious diseases, hormones, cardiovascular diseases, tumors, cancers, diabetes, autoimmune diseases and the like, and the non-clinical samples comprise samples of food detection, environmental pollution detection, pesticide residue detection, biological contamination detection, biological agent detection, veterinary medicine detection, drug detection and the like.
It should be pointed out that the test strip card of the present invention can also have other improvements, for example, the storage medium 12 storing the information for detection such as the standard curve of the detected object can be directly installed on the test strip 2 in the test strip card besides being installed on the card box 3 of the test strip card; the test strip in the cartridge 3 can be expanded and replaced by a biochip (including antigen-antibody chip, protein chip, nucleic acid chip, microfluidic chip) and the like based on the same principle of the invention. Therefore, any other technical solutions formed by any equivalent replacement or equivalent transformation on the test strip card of the present invention fall within the protection scope of the claims of the present invention.
Claims (3)
1. The utility model provides a test strip card, including card box (3) and test strip (2) in it, test strip (2) are including sample pad (4) of overlap joint fixing on end liner (1) in order, mark pad (5), analysis membrane (8), absorb water and fill up (9), analysis membrane (8) have test tape (6) and quality control area (7), test tape (6) are one or many, the last box face of card box (3) is being opened corresponding to test strip sample pad (4) position department and is having application of sample hole (10), the last box face of card box (3) is being opened corresponding to test strip analysis membrane (8) position department and is having detection window (11), its characterized in that: the card box (3) is also provided with a storage medium (12);
the marking pad (5) of the test strip (2) is coated with a single marker-labeled single specific molecule related to detection of a certain target test object, or: a mixture of specific molecules related to detection of each target object coated with corresponding markers of different markers; the detection belt (6) of the test strip (2) is coated with another specific molecule related to the detection of a target detected object, or: a mixture coated with another specific molecule related to the detection of each target test substance; the quality control belt (7) of the test strip (2) is coated with a quality control substance comprising a secondary antibody;
the storage medium (12) on the card box (3) comprises an RFID label, an IC chip, a magnetic code or a bar code;
the storage medium (12) is stored with a detected object standard curve or coefficient parameter for quantifying the sample concentration of the test strip (2) in the same batch, a reference monitoring value of the signal intensity of a test strip quality control signal, a test strip batch number, a test strip validity period, a storage medium password, a clinical index reference value and test strip manufacturer information, and can read the identity information, the information of a detector, a sample name, a sample number, a detection date and detection result information of a detected object;
the standard curve of the detected object stored in the storage medium (12) has various forms which can be selected, and the standard curve comprises: concentration of standard substance series to be detectedA Detection belt/A Quality control bandThe corresponding relation curve between the two curves; or, the concentration of the standard substance series of the object to be tested andA detection belt/（A Detection belt+A Quality control band) The corresponding relation curve between the two curves; wherein,A detection beltThe signal intensity of the detection zone measured for the series concentration of the object standard,A quality control bandSignal intensity of quality control band measured for series concentration of detected object standard;
the marking pad (5) of the test strip (2) is a glass fiber film; the analysis membrane (8) of the test strip (2) is a nitrocellulose membrane, a nylon membrane or a mixed membrane of nitrocellulose and cellulose acetate; the bottom lining (1) of the test strip (2) is made of polyester or a plastic plate; the card box (3) is made of polyester, plastic or hard paper material;
the test strip (2) is any test strip, and comprises a quantum dot marking test strip, a colloidal gold marking test strip, a colloidal selenium marking test strip, an up-conversion phosphor marking test strip, a nano rare earth fluorescent complex marking test strip, a nano magnetic particle marking test strip, a time resolution chromatography test strip and a chemiluminescence test strip;
when detecting a sample, an instrument with a signal detection function collects characteristic signals of a detection band (6) and a quality control band (7) of a test strip (2) in a test strip card and quantitatively obtains the single-component or multi-component concentration of the sample by combining a standard curve or coefficient parameter of the detected object, which is simultaneously read from a storage medium (12) by the instrument; or, in the sample detection, the components of the sample are qualitatively or semi-quantitatively detected according to the display conditions of the test strip detection band (6) and the quality control band (7) of the test strip card.
2. The test strip card of claim 1, wherein: wherein a test strip reaction end point indicating label (13) is lapped behind the water absorption pad (9) of the test strip (2); an observation window (14) is arranged at the corresponding position of the test strip reaction end point indicator label (13) of the card box (3);
the test strip reaction end point indicator label (13) comprises pH test paper with the color change range of 5-9;
the marking pad (5) of the test strip (2) is coated with a single marker-labeled single specific molecule related to detection of a certain target test object, or: a mixture of specific molecules related to detection of each target object coated with corresponding markers of different markers; the detection belt (6) of the test strip (2) is coated with another specific molecule related to the detection of a target detected object, or: a mixture coated with another specific molecule related to the detection of each target test substance; the quality control belt (7) of the test strip (2) is coated with a quality control substance comprising a secondary antibody;
the storage medium (12) on the card box (3) comprises an RFID label, an IC chip, a magnetic code or a bar code;
the storage medium (12) is stored with a detected object standard curve or coefficient parameter for quantifying the sample concentration of the test strip (2) in the same batch, a reference monitoring value of the signal intensity of a test strip quality control signal, a test strip batch number, a test strip validity period, a storage medium password, a clinical index reference value and test strip manufacturer information, and can read the identity information, the information of a detector, a sample name, a sample number, a detection date and detection result information of a detected object;
the standard curve of the detected object stored in the storage medium (12) has various forms which can be selected, and the standard curve comprises: concentration of standard substance series to be detectedA Detection belt/A Quality control bandThe corresponding relation curve between the two curves; or, the concentration of the standard substance series of the object to be tested andA detection belt/（A Detection belt+A Quality control band) The corresponding relation curve between the two curves; wherein,A detection beltThe signal intensity of the detection zone measured for the series concentration of the object standard,A quality control bandSignal intensity of quality control band measured for series concentration of detected object standard;
the marking pad (5) of the test strip (2) is a glass fiber film; the analysis membrane (8) of the test strip (2) is a nitrocellulose membrane, a nylon membrane or a mixed membrane of nitrocellulose and cellulose acetate; the bottom lining (1) of the test strip (2) is made of polyester or a plastic plate; the card box (3) is made of polyester, plastic or hard paper material;
the test strip (2) is any test strip, and comprises a quantum dot marking test strip, a colloidal gold marking test strip, a colloidal selenium marking test strip, an up-conversion phosphor marking test strip, a nano rare earth fluorescent complex marking test strip, a nano magnetic particle marking test strip, a time resolution chromatography test strip and a chemiluminescence test strip;
when detecting a sample, an instrument with a signal detection function collects characteristic signals of a detection band (6) and a quality control band (7) of a test strip (2) in a test strip card and quantitatively obtains the single-component or multi-component concentration of the sample by combining a standard curve or coefficient parameter of the detected object, which is simultaneously read from a storage medium (12) by the instrument; or, in the sample detection, the components of the sample are qualitatively or semi-quantitatively detected according to the display conditions of the test strip detection band (6) and the quality control band (7) of the test strip card.
3. The test strip card of claim 1 or 2, wherein: the sample to be detected is clinical or non-clinical blood, body fluid, urine, saliva, genital secretion or other liquid samples or viscous samples, wherein the clinical samples comprise samples of infectious diseases, hormones, cardiovascular diseases, tumors, cancers, diabetes and autoimmune diseases, and the non-clinical samples comprise samples of food detection, environmental pollution detection, pesticide residue detection, biological contamination detection, biological agent detection, veterinary medicine detection and drug detection.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310565236.5A CN103630684A (en) | 2013-11-13 | 2013-11-13 | Test strip card |
| PCT/CN2014/089637 WO2015070703A1 (en) | 2013-11-13 | 2014-10-28 | Test strip card |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310565236.5A CN103630684A (en) | 2013-11-13 | 2013-11-13 | Test strip card |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103630684A true CN103630684A (en) | 2014-03-12 |
Family
ID=50211949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310565236.5A Pending CN103630684A (en) | 2013-11-13 | 2013-11-13 | Test strip card |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN103630684A (en) |
| WO (1) | WO2015070703A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103645312A (en) * | 2013-11-16 | 2014-03-19 | 成都领御生物技术有限公司 | Test strip card |
| WO2015070704A1 (en) * | 2013-11-13 | 2015-05-21 | 成都领御生物技术有限公司 | Test bar card |
| WO2015070700A1 (en) * | 2013-11-12 | 2015-05-21 | 成都领御生物技术有限公司 | Quantum dot-labeled test strip card |
| WO2015070699A1 (en) * | 2013-11-12 | 2015-05-21 | 成都领御生物技术有限公司 | Quantum dot-labeled test strip card |
| WO2015070703A1 (en) * | 2013-11-13 | 2015-05-21 | 成都领御生物技术有限公司 | Test strip card |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000007015A1 (en) * | 1998-07-29 | 2000-02-10 | Syntron Bioresearch, Inc. | Immunoassay device |
| US20060008920A1 (en) * | 2004-07-09 | 2006-01-12 | Branan Medical Corporation | Combination assay for alcohol and drugs of abuse |
| WO2012129650A1 (en) * | 2011-03-25 | 2012-10-04 | Nanospeed Diagnostics Inc. | Lateral flow immunoassay for detecting vitamins |
| CN103091486A (en) * | 2011-11-01 | 2013-05-08 | 马义才 | Test strip detection system |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100099112A1 (en) * | 2004-06-02 | 2010-04-22 | Siliang Zhou | Quantitative lateral flow system and assay |
| EP1787121B1 (en) * | 2004-07-29 | 2010-08-25 | Relia Diagnostic Systems, LLC | Lateral flow system and assay |
| CN101762690A (en) * | 2009-06-24 | 2010-06-30 | 北京科美东雅生物技术有限公司 | Magnetic immuno-chromatographic test paper strip for quantitatively detecting C-reactive protein in blood and preparation method thereof |
| CN101750498A (en) * | 2009-10-16 | 2010-06-23 | 北京科美东雅生物技术有限公司 | Magnetic immunochromatographic test strip for detecting hepatitis B e antigen and preparation method thereof |
| CN201724940U (en) * | 2009-12-22 | 2011-01-26 | 王继华 | Immunochromatographic test strip with bar code layer |
| CN103267843B (en) * | 2013-06-08 | 2015-11-18 | 张沈平 | Colloidal gold test paper card, corresponding collaurum analyser and method of testing |
| CN203759009U (en) * | 2013-11-12 | 2014-08-06 | 成都领御生物技术有限公司 | Quantum dot labeled test strip card |
| CN103630681A (en) * | 2013-11-12 | 2014-03-12 | 成都领御生物技术有限公司 | Test strip card based on quantum dot labeling |
| CN203759015U (en) * | 2013-11-13 | 2014-08-06 | 成都领御生物技术有限公司 | Test strip card |
| CN103630684A (en) * | 2013-11-13 | 2014-03-12 | 成都领御生物技术有限公司 | Test strip card |
-
2013
- 2013-11-13 CN CN201310565236.5A patent/CN103630684A/en active Pending
-
2014
- 2014-10-28 WO PCT/CN2014/089637 patent/WO2015070703A1/en active Application Filing
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000007015A1 (en) * | 1998-07-29 | 2000-02-10 | Syntron Bioresearch, Inc. | Immunoassay device |
| US20060008920A1 (en) * | 2004-07-09 | 2006-01-12 | Branan Medical Corporation | Combination assay for alcohol and drugs of abuse |
| WO2012129650A1 (en) * | 2011-03-25 | 2012-10-04 | Nanospeed Diagnostics Inc. | Lateral flow immunoassay for detecting vitamins |
| CN103091486A (en) * | 2011-11-01 | 2013-05-08 | 马义才 | Test strip detection system |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015070700A1 (en) * | 2013-11-12 | 2015-05-21 | 成都领御生物技术有限公司 | Quantum dot-labeled test strip card |
| WO2015070699A1 (en) * | 2013-11-12 | 2015-05-21 | 成都领御生物技术有限公司 | Quantum dot-labeled test strip card |
| WO2015070704A1 (en) * | 2013-11-13 | 2015-05-21 | 成都领御生物技术有限公司 | Test bar card |
| WO2015070703A1 (en) * | 2013-11-13 | 2015-05-21 | 成都领御生物技术有限公司 | Test strip card |
| CN103645312A (en) * | 2013-11-16 | 2014-03-19 | 成都领御生物技术有限公司 | Test strip card |
| WO2015070749A1 (en) * | 2013-11-16 | 2015-05-21 | 成都领御生物技术有限公司 | Test strip card |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015070703A1 (en) | 2015-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203759015U (en) | Test strip card | |
| WO2015070701A1 (en) | Test strip card | |
| CN203759017U (en) | Test strip card | |
| WO2015070702A1 (en) | Test strip card | |
| CN103675268A (en) | Test strip card | |
| WO2015070745A1 (en) | Test strip card marked by quantum dots | |
| WO2015070704A1 (en) | Test bar card | |
| WO2015070699A1 (en) | Quantum dot-labeled test strip card | |
| WO2015070750A1 (en) | Test strip card | |
| WO2015070748A1 (en) | Test strip card | |
| JP5908101B2 (en) | Test strip detection system | |
| WO2015070749A1 (en) | Test strip card | |
| CN101592659B (en) | System and method for quantitative detection of test strips on basis of continuous fluorescent-substance markers | |
| WO2015070700A1 (en) | Quantum dot-labeled test strip card | |
| CN203759009U (en) | Quantum dot labeled test strip card | |
| CN203759014U (en) | Test strip card | |
| JP2008304477A (en) | Accessible assay system and its usage | |
| WO2015070703A1 (en) | Test strip card | |
| EP1666879B1 (en) | Read-write assay system | |
| CN201535776U (en) | Quantitative detection system based on test strip marked with constantly illuminating material | |
| WO2015070746A1 (en) | Test strip card marked by quantum dots | |
| CN203759016U (en) | Test strip card | |
| CN203606364U (en) | Test strip card | |
| CN104267182A (en) | Quantum dot immunochromatographic strip for synchronously quantifying multiple tumor markers and method of quantum dot immunochromatographic strip | |
| CN203759011U (en) | Quantum dot labeled test strip card |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140312 |